177Lu-PSMA-617 Therapy in a Patient on Haemodialysis with End Stage Renal Failure

被引：0
|
作者：
MacFarlane, L. [1 ]
Eifer, M. [1 ]
Saghebi, J. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-508
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [31] Prognostic value of baseline imaging parameters prior to therapy with 177Lu-PSMA-617
    Ferdinandus, Justin
    Thang, Sue Ping
    Violet, John
    Hicks, Rodney
    Sandhu, Shahneen
    Hofman, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [32] Management of Dry Mouth Toxicity Following 177Lu-PSMA-617 Radioligand Therapy
    Pepin, Abigail
    Kiess, Ana
    Lukens, J. Nicholas
    Mulugeta, Philipose
    Taunk, Neil K.
    PRACTICAL RADIATION ONCOLOGY, 2025, 15 (01) : 14 - 18
  • [33] Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
    Pathmanandavel, Sarennya
    Crumbaker, Megan
    Ho, Bao
    Yam, Andrew O.
    Wilson, Peter
    Niman, Remy
    Ayers, Maria
    Sharma, Shikha
    Hickey, Adam
    Eu, Peter
    Stockler, Martin
    Martin, Andrew J.
    Joshua, Anthony M.
    Nguyen, Andrew
    Emmett, Louise
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (02) : 221 - 226
  • [34] Risk and Concomitant Factors of Renal Insufficiency throughout Radioligand Treatment with 177Lu-PSMA-617
    Ngoc, C. Nguyen
    Mader, N.
    Davis, K.
    Groener, D.
    Happel, C.
    Mandel, P.
    Tselis, N.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S490 - S490
  • [35] Production and radiochemical purity of 177Lu-PSMA-617 for clinical trial
    Asad, Ali
    Scharli, Rainer
    Morandeau, Laurence
    Price, Roger
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S527 - S527
  • [36] The 177Lu-PSMA-617 (Pluvicto) Supply Problem Will Be Solved by Competition
    Czernin, Johannes
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (03) : 343 - 343
  • [37] Value of Post-Therapy Quantitative SPECT for Monitoring Response to 177Lu-PSMA-617 Therapy
    Meyer, Catherine
    Yilmaz, Burcak
    Szidonya, Laszlo
    Winters, Celeste
    Mench, Anna
    Mallak, Nadine
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [38] Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC A Proof-of-Principle Application
    Bal, Chandrasekhar
    Yadav, Madhav Prasad
    Ballal, Sanjana
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (08) : E386 - E387
  • [39] Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection
    Yadav, Surekha
    Kim, Sarasa T.
    Tuchayi, Abuzar Moradi
    Jiang, Fei
    Morley, Amanda
    Saelee, Rachelle
    Wang, Yingbing
    Juarez, Roxanna
    Lawnh-Heath, Courtney
    Koshkin, Vadim S.
    Hope, Thomas A.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Patient-specific tumor dosimetry in mCRPC patients treated with 177Lu-PSMA-617
    Meyer, Catherine
    Mirando, David
    Adams, Tim
    Czernin, Johannes
    Calais, Jeremie
    Dahlbom, Magnus
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
12345